Clinical Trial Update: A Pilot Study of Edoxaban in Patients With Non-Valvular Atrial Fibrillation and Left Atrial Appendage Closure [Phase 4]

View source ↗

Summary

A Phase 4 trial is evaluating edoxaban in patients with non-valvular atrial fibrillation undergoing left atrial appendage closure; the trial status is currently…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-valvular Atrial Fibrillation

Drugs mentioned

• Edoxaban (edoxaban)

Snippet

Sponsor: Scripps Health | Conditions: Non-Valvular Atrial Fibrillation, Left Atrial Appendage Closure | Phase 4 | Status: UNKNOWN